Cancer BiologyCell Death and DiseasePeer-reviewed
A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: Repurposing drugs to disrupt 14-3-3 protein-BAD interactions
Siyi He, Daniel L. Meister, Samra Khan…·Gareth E. Lim
This paper uses a BRET-based high-throughput screen to identify FDA-approved drugs that disrupt 14-3-3{zeta}BAD interactions, showing potential for colorectal cancer treatment.
5 citations